Consolidated Statements Of Earnings (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Net sales	$ 2,305	$ 2,190
Cost of sales	769	713
Gross profit	1,536	1,477
Research, development and engineering expenses	150	129
Selling, general and administrative expenses	1,205	916
Intangible asset amortization	45	32
Restructuring charges	5	14
Total operating expenses	1,405	1,091
Operating income	131	386
Other income (expense), net	(24)	(11)
Earnings before income taxes	107	375
Income taxes	37	71
Net earnings	$ 70	$ 304
Net earnings per share of common stock:
Basic net earnings per share of common stock	$ 0.19	$ 0.80
Diluted net earnings per share of common stock	$ 0.18	$ 0.79
Weighted-average shares outstanding—in millions:
Basic	378.2	379.7
Net effect of dilutive employee stock options	4.4	3.3
Diluted	382.6	383.0
Anti-dilutive shares excluded from the calculation of net effect of dilutive employee stock options	2.5	5.1